Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yu Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6561-7827; OpenAlex author ID A5086372726. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 3 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase-Independent Manner. Last author DOI 10.1002/advs.202407942↗
  2. The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway. Last author DOI 10.1007/s12094-021-02747-x↗
  3. Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12094-022-02864-1↗
  4. Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2021.121306↗
  5. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. First author DOI 10.1016/j.biomaterials.2020.120546↗
  6. OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngen… Co-author PMID 34249428↗
  7. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. Co-author DOI 10.1016/j.apsb.2019.11.013↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Changlin Zhou · 2 shared papers, 2022–2025 · strength 0.47
  2. Xiaoyi Ding · 3 shared papers, 2020–2022 · strength 0.41
  3. Wenxi Zhou · 3 shared papers, 2020–2022 · strength 0.35
  4. Xinli Chen · 3 shared papers, 2020–2022 · strength 0.35
  5. Qiwei Zhang · 2 shared papers, 2021–2022 · strength 0.30
  6. Xuanning Chu · 1 shared paper, 2025 · strength 0.28
  7. Qingbing Wang · 2 shared papers, 2020–2021 · strength 0.26
  8. Tao Sun · 2 shared papers, 2021–2022 · strength 0.24
  9. Hongyi Chen · 2 shared papers, 2021–2022 · strength 0.24
  10. Qinjun Chen · 2 shared papers, 2020–2022 · strength 0.23
  11. Chen Jiang · 2 shared papers, 2020–2021 · strength 0.23
  12. B. Li · 1 shared paper, 2022 · strength 0.19
  13. Shuyang Pang · 1 shared paper, 2022 · strength 0.19
  14. Baiyong Shen · 1 shared paper, 2022 · strength 0.19
  15. Yongsheng Jiang · 1 shared paper, 2022 · strength 0.15
  16. Yu Wang · 1 shared paper, 2022 · strength 0.12
  17. Chen Liang · 1 shared paper, 2022 · strength 0.12
  18. Yifan Luo · 1 shared paper, 2022 · strength 0.12
  19. Xianjun Yu · 1 shared paper, 2022 · strength 0.12
  20. Si Shi · 1 shared paper, 2022 · strength 0.12
  21. Chen Jiang · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.